Mark Shelly

968 total citations
30 papers, 726 citations indexed

About

Mark Shelly is a scholar working on Epidemiology, Infectious Diseases and Emergency Medical Services. According to data from OpenAlex, Mark Shelly has authored 30 papers receiving a total of 726 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Epidemiology, 7 papers in Infectious Diseases and 6 papers in Emergency Medical Services. Recurrent topics in Mark Shelly's work include Central Venous Catheters and Hemodialysis (6 papers), Pneumonia and Respiratory Infections (5 papers) and Patient Satisfaction in Healthcare (4 papers). Mark Shelly is often cited by papers focused on Central Venous Catheters and Hemodialysis (6 papers), Pneumonia and Respiratory Infections (5 papers) and Patient Satisfaction in Healthcare (4 papers). Mark Shelly collaborates with scholars based in United States, Israel and Italy. Mark Shelly's co-authors include James A. Sloand, Andrew Feigin, Rebeca D. Monk, Paul Bernstein, Michael E. Pichichero, Robert H. Poe, John J. Treanor, Gregory J. Riley, Barbara Graves and Moon H. Nahm and has published in prestigious journals such as Clinical Infectious Diseases, Journal of Clinical Microbiology and The Journal of Infectious Diseases.

In The Last Decade

Mark Shelly

28 papers receiving 696 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Shelly United States 13 434 143 119 104 67 30 726
Eduardo Padilla Spain 18 621 1.4× 35 0.2× 521 4.4× 23 0.2× 13 0.2× 45 1.2k
Naoto Hosokawa Japan 15 245 0.6× 40 0.3× 157 1.3× 11 0.1× 129 1.9× 66 639
E. Bosdure France 16 239 0.6× 48 0.3× 204 1.7× 109 1.0× 5 0.1× 78 816
Gayane Martirosian Poland 18 334 0.8× 129 0.9× 505 4.2× 9 0.1× 21 0.3× 96 1.2k
Şükrü Arslan Türkiye 12 245 0.6× 24 0.2× 145 1.2× 25 0.2× 4 0.1× 60 639
Hee Jung Yoon South Korea 16 298 0.7× 42 0.3× 261 2.2× 18 0.2× 18 0.3× 70 786
Virginia Pomar Spain 20 382 0.9× 152 1.1× 328 2.8× 237 2.3× 2 0.0× 43 1.2k
Mi Young Ahn South Korea 11 96 0.2× 12 0.1× 275 2.3× 118 1.1× 29 0.4× 34 686
Kaifeng Wu China 16 294 0.7× 126 0.9× 76 0.6× 11 0.1× 10 0.1× 47 757
Kristen Ries United States 14 387 0.9× 36 0.3× 854 7.2× 33 0.3× 21 0.3× 22 1.5k

Countries citing papers authored by Mark Shelly

Since Specialization
Citations

This map shows the geographic impact of Mark Shelly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Shelly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Shelly more than expected).

Fields of papers citing papers by Mark Shelly

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Shelly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Shelly. The network helps show where Mark Shelly may publish in the future.

Co-authorship network of co-authors of Mark Shelly

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Shelly. A scholar is included among the top collaborators of Mark Shelly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Shelly. Mark Shelly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Martínez, Raquel, et al.. (2022). Acremonium (Sarocladium) periprosthetic joint infection: case report, literature review, and proposed antifungal regimen. BMC Infectious Diseases. 22(1). 964–964. 2 indexed citations
2.
Shelly, Mark, et al.. (2019). Implementing Clinical Practice Guidelines for Replacing Peripheral Intravenous Catheters. Journal of Nursing Care Quality. 35(2). 108–114. 10 indexed citations
3.
Felsen, Christina B., Paul Graman, Linda Greene, et al.. (2015). City-Wide Collaboration to Reduce Clostridium difficile Infections. Open Forum Infectious Diseases. 2(suppl_1). 2 indexed citations
4.
Dumyati, Ghinwa, Cathleen Concannon, Edwin van Wijngaarden, et al.. (2014). Sustained reduction of central line–associated bloodstream infections outside the intensive care unit with a multimodal intervention focusing on central line maintenance. American Journal of Infection Control. 42(7). 723–730. 25 indexed citations
5.
Banfi, Giuseppe, James A. Sloand, Mark Shelly, et al.. (2012). Limitations of Cockcroft-Gault and MDRD formulas in estimating GFR among top-level rugby players. Journal of Nephrology. 25(6). 1047–1053. 6 indexed citations
6.
Shelly, Mark, et al.. (2011). Device Use Ratio Measured Weekly Can Reliably Estimate Central Line–Days for Central Line–Associated Bloodstream Infection Rates. Infection Control and Hospital Epidemiology. 32(7). 727–730. 12 indexed citations
7.
Dumyati, Ghinwa, et al.. (2011). The Challenges in Implementing a Central Line Related Bloodstream Infection (CLABSI) Prevention Outside the ICU through a Multihospital Collaborative. American Journal of Infection Control. 39(5). E138–E138. 2 indexed citations
8.
Moore, Matthew R., John J. Treanor, Stephen I. Pelton, et al.. (2008). Differential Effects of Pneumococcal Vaccines against Serotypes 6A and 6C. The Journal of Infectious Diseases. 198(12). 1818–1822. 127 indexed citations
9.
Sloand, James A. & Mark Shelly. (2006). Normalization of Lithium-Induced Hypercalcemia and Hyperparathyroidism With Cinacalcet Hydrochloride. American Journal of Kidney Diseases. 48(5). 832–837. 39 indexed citations
10.
Sloand, James A., Mark Shelly, Andrew Feigin, Paul Bernstein, & Rebeca D. Monk. (2004). A double-blind, placebo-controlled trial of intravenous iron dextran therapy in patients with ESRD and restless legs syndrome. American Journal of Kidney Diseases. 43(4). 663–670. 154 indexed citations
11.
12.
Shelly, Mark. (2002). :Legionella. Clinical Infectious Diseases. 35(7). 905–905. 1 indexed citations
13.
Sloand, James A., et al.. (2001). Success of Prolonged Hibernation of Subcutaneously-Placed Peritoneal Dialysis Catheters. Peritoneal Dialysis International. 21(6). 618–620. 4 indexed citations
14.
Sloand, James A., et al.. (1998). Safety and Efficacy of Total Dose Iron Dextran Administration in Patients on Home Renal Replacement Therapies. Peritoneal Dialysis International. 18(5). 522–527. 8 indexed citations
15.
Shelly, Mark, et al.. (1997). Comparison of pneumococcal polysaccharide and CRM197-conjugated pneumococcal oligosaccharide vaccines in young and elderly adults. Infection and Immunity. 65(1). 242–247. 89 indexed citations
16.
Pichichero, Michael E., Mark Shelly, & John J. Treanor. (1997). EVALUATION OF A PENTAVALENT CONJUGATED PNEUMOCOCCAL VACCINE IN TODDLERS. The Pediatric Infectious Disease Journal. 16(1). 72–74. 29 indexed citations
17.
Shelly, Mark, et al.. (1996). Pulmonary Mycetoma Due to Candida albicans: Case Report and Review. Clinical Infectious Diseases. 22(1). 133–135. 49 indexed citations
18.
Shelly, Mark. (1996). Exploratory Data Analysis: Data Visualization or Torture?. Infection Control and Hospital Epidemiology. 17(9). 605–612. 5 indexed citations
19.
Pettis, Ann Marie, et al.. (1995). Polymicrobial gram-negative bacteremia associated with saline solution flush used with a needleless intravenous system. American Journal of Infection Control. 23(6). 357–363. 22 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eduardo Padilla Breakdown of academic impact, for papers by Naoto Hosokawa Breakdown of academic impact, for papers by E. Bosdure Breakdown of academic impact, for papers by Gayane Martirosian Breakdown of academic impact, for papers by Şükrü Arslan Breakdown of academic impact, for papers by Hee Jung Yoon Breakdown of academic impact, for papers by Virginia Pomar Breakdown of academic impact, for papers by Mi Young Ahn Breakdown of academic impact, for papers by Kaifeng Wu Breakdown of academic impact, for papers by Kristen Ries
Rankless by CCL
2026